Concepedia

J. Berlin

JB

Statistics

Publications

11

Citations

210

H-Index

10

Active since

2004

Affiliations

Kaiser Permanente(Current)

Vanderbilt University

Sarah Cannon

Duke University

University of Colorado Denver

J. Berlin is an author at Kaiser Permanente specializing in oncology, medicine, and pharmacology.

Publications per year

2004–2017

11

Publications

11

Bevacizumab plus irinotecan/5-FU/leucovorin for treatment of metastatic colorectal cancer results in survival benefit in all pre-specified patient subgroups

G. Fyfe, H. Hurwitz, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2004 · 36 citations

, , +17

Bevacizumab does not increase bleeding in patients with metastatic colorectal cancer receiving concurrent anticoagulation

J. Hambleton, William Novotny, Herbert I. Hurwitz et al. · Journal of Clinical Oncology · 2004 · 28 citations

, , +13

Final results from cohort 1 of a phase II study of volociximab, an anti-α5β1 integrin antibody, in combination with gemcitabine (GEM) in patients (pts) with metastatic pancreatic cancer (MPC)

Thomas Evans, Rajesh Ramanathan, Salim Yazji et al. · Journal of Clinical Oncology · 2007 · 25 citations

, , +17

A first in human phase 1 study of KPT-9274, a first in class dual inhibitor of PAK4 and NAMPT, in patients with advanced solid malignancies or NHL

Aung Naing, Stephen Leong, Michael J. Pishvaian et al. · Annals of Oncology · 2017 · 24 citations · Full text

, , +16

Bevacizumab plus irinotecan/5-FU/leucovorin for treatment of metastatic colorectal cancer results in survival benefit in all pre-specified patient subgroups

G. Fyfe, Herbert I. Hurwitz, L. Fehrenbacher et al. · Journal of Clinical Oncology · 2004 · 20 citations

, , +17

1–5 of 11